LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

Начало・Списък с акции・Vivani Medical

Vivani Medical

Затворен

1.2 11.11

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.11

Максимум

1.25

Ключови измерители
By Trading Economics
Приходи	614K -6.5M
Служители	37

Дивиденти
By Dow Jones
Следващи печалби	30.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-25M 79M
Предишно отваряне	-9.91
Предишно затваряне	1.2

Vivani Medical Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.03.2026 г., 21:14 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15.03.2026 г., 21:14 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16.03.2026 г., 00:00 ч. UTC

Значими събития в новините

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15.03.2026 г., 23:45 ч. UTC

Пазарно говорене

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15.03.2026 г., 23:44 ч. UTC

Пазарно говорене

Значими събития в новините

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15.03.2026 г., 23:35 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15.03.2026 г., 23:00 ч. UTC

Придобивния, сливания и поглъщания

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15.03.2026 г., 22:37 ч. UTC

Пазарно говорене

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15.03.2026 г., 22:18 ч. UTC

Пазарно говорене

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15.03.2026 г., 22:14 ч. UTC

Печалби

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15.03.2026 г., 22:00 ч. UTC

Значими събития в новините

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15.03.2026 г., 22:00 ч. UTC

Значими събития в новините

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15.03.2026 г., 03:00 ч. UTC

Значими събития в новините

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14.03.2026 г., 15:00 ч. UTC

Значими събития в новините

Iran War Delivers Windfall to America's Oil Country -- WSJ

14.03.2026 г., 02:03 ч. UTC

Печалби

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14.03.2026 г., 01:32 ч. UTC

Придобивния, сливания и поглъщания

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14.03.2026 г., 00:29 ч. UTC

Придобивния, сливания и поглъщания

13D Filings -- Barrons.com

13.03.2026 г., 22:27 ч. UTC

Пазарно говорене

Значими събития в новините

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13.03.2026 г., 22:13 ч. UTC

Пазарно говорене

Значими събития в новините

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13.03.2026 г., 22:04 ч. UTC

Пазарно говорене

Значими събития в новините

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13.03.2026 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

13.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Значими събития в новините

Financial Services Roundup: Market Talk

13.03.2026 г., 20:02 ч. UTC

Пазарно говорене

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13.03.2026 г., 19:50 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13.03.2026 г., 19:35 ч. UTC

Значими събития в новините

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Vivani Medical Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Vivani Medical през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Печалба преди облагане с данъци

Продажби

Оперативна печалба

Относно Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.